Streamlining Combination Device Development

New product launches are exciting times for manufactures bringing new products to market and patients awaiting new treatments. In recent years, innovation has resulted in new regulatory structures and processes for evaluating products prior to entering the market. An example of this is the formation of the Office of Combination Products (FDA – 2002) and new guidance documents related to human factors and technical considerations of combination products. Read More >